Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Are the Latest Market Insights for the Antibody Discovery Industry?

In recent years, the antibody discovery market has experienced significant growth. The market is set to expand from a value of $8.96 billion in 2024 to $9.78 billion in 2025, with a compound annual growth rate (CAGR) of 9.2%. Trends such as substantial investments in drug discovery, increased funding in research and development efforts, and the existence of multiple healthcare research organizations and educational institutions have contributed to the growth witnessed in the historic period.

The market size of antibody discovery is predicted to experience robust expansion in the coming few years. Its projected growth rate will reach “$14.31 billion in 2029, with a compound annual growth rate (CAGR) of 10.0%.” The anticipated growth in the forecast period can be ascribed to the escalating demand for services and platforms related to antibody drug discovery, the spike in funding aimed at developing cutting-edge technologies, the rising demand for precision-based therapeutics, and the expansion of antibody use beyond the traditional therapeutic fields. Key trends in the forecasted period involve increased R&D activities, rising demand for monoclonal antibodies, greater adoption of state-of-the-art technologies, growing preference for targeted therapeutics, and the emergence of innovative antibody formats.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13783&type=smp

What Forces Are Driving The Growth Of The Antibody Discovery Industry?

The rising demand for precision therapeutics is anticipated to boost the expansion of the antibody discovery market. Precision therapeutics, otherwise known as personalized therapeutics, is the modification of medical treatments and strategies to suit each patient’s distinctive traits. Antibody discovery plays a significant role in precision therapeutics by making it possible to create targeted therapies, like monoclonal antibodies, planned to specifically and accurately interact with molecules or cells related to disease for more efficient and personalized healthcare. For example, back in January 2023, as stated by the Personalized Medicine Coalition, a professional membership organization in the US, the FDA’s Center for Drug Evaluation and Research (CDER) gave approval to 37 new molecular entities (NMEs) in 2022 and about 34%, or 12 out of the 35 therapeutic NMEs, were identified as personalized medicines by the Personalized Medicine Coalition (PMC). Hence, the increasing demand for precision therapeutics is anticipated to stimulate the expansion of the antibody discovery market.

The antibody discovery market covered in this report is segmented –

1) By Methods: Phage Display, Hybridoma, Other Methods

2) By Antibody Type: Humanized Antibody, Human Antibody, Chimeric Antibody, Murine Antibody

3) By End Users: Pharmaceutical And Biotechnology Industry, Research Laboratory, Academic Laboratory

Subsegments:

1) By Phage Display: Selection And Screening Techniques, Optimization Methods

2) By Hybridoma: Monoclonal Antibody Production, Screening And Selection Processes

3) By Other Methods: Transgenic Mouse Technology, B-Cell Engineering, Single-Cell Sorting Techniques

Which Emerging Trends And Strategic Shifts Are Shaping The Antibody Discovery Market?

Leading firms in the antibody discovery market are pioneering novel technologies such as the AI-based computational antibody drug discovery platform, which enhances the speed and accuracy of antibody production. The AI-based computational antibody drug discovery platform incorporates artificial intelligence and computational methods to accelerate the discovery and refinement of therapeutic antibodies. For instance, SwiftPharma BV, a Belgium-based firm specialized in developing recombinant proteins from a unique plant-based system, launched an AI-powered antibody discovery platform in October 2023. This revolutionary tool merges artificial intelligence, big data, machine learning, and phage display techniques to swiftly predict antibody-antigen binding with high specificity and affinity. This technique, similar to natural language processing, produces diverse antibody variations, allowing SwiftPharma to efficiently build comprehensive antibody libraries. This cutting-edge system hastens the discovery of potential antibody drugs at an unparalleled rate.

Who Are The Primary Players Operating Across The Global Antibody Discovery Market?

Major companies operating in the antibody discovery market report are Danaher Corporation, Eurofins Scientific, Sartorius AG, Charles River Laboratories, Bruker Corporation, WuXi Biologics, Genmab A/S, Evotec, Cambrex corporation, ChemPartner, Aragen life science Pvt ltd, Genscript Technology Corporation, Biocytogen, Alcami Corporation Inc, Twist Bioscience, BioDuro-Sundia, Fairjourney Biologics S.A, Harbour BioMed, Rockland Immunochemicals, Creative Biolabs, Synbio technologies, ImmunoPrecise, Ablexis, Myrio Therapeutics, Antibody Solutions, MabSilico

https://www.thebusinessresearchcompany.com/report/antibody-discovery-global-market-report

Which Region Offers The Most Growth Potential For The Antibody Discovery Market Through 2029?

North America was the largest region in the antibody discovery market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the antibody discovery market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=13783&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model